Overview

A Study for Patients With Relapsing Remitting Multiple Sclerosis

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test if dirucotide is safe and effective in treating patients with relapsing remitting multiple sclerosis.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Collaborator:
BioMS Technology Corp.